Down-regulation of spontaneous Epstein-Barr virus reactivation in the P3HR-1 cell line by L-arginine

Virology

Volumn 304, Issue 1, 2002, Pages 114-124

  Agawa, Hideyuki ^a   Ikuta, Kazufumi ^a   Minamiyama, Yukiko ^b   Inoue, Masayasu ^b   Sairenji, Takeshi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; IMMEDIATE EARLY PROTEIN; MESSENGER RNA; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; VIRUS ANTIGEN;

ARTICLE; B LYMPHOBLAST; BURKITT LYMPHOMA; CELL CULTURE; CELL GROWTH; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INDUCTION; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REACTIVATION;

HUMAN HERPESVIRUS 4;

EID: 0036939497     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2002.1709     Document Type: Article

References (73)

1. Akarid, K., Sinet, M., Desforges, B., and Gougerot Pocidalo, M. A. (1995). Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol. 69, 7001-7005.
2. Bayliss, G. J., and Wolf, H. (1982). Effect of the arginine analog Canavanine on the synthesis of Epstein-Barr virus-induced proteins in superinfected Raji cells. J. Virol. 41, 1109-1111.
3. Chevallier-Greco, A., Manet, E., Chavrier, P., Mosnier, C., Daillie, J., and Sergeant, A. (1986). Both Epstein-Barr virus (EBV)-encoded transacting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J. 5, 3243-3249.
4. Countryman, J., and Miller, G. (1985). Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82, 4085-4089.
5. Croen, K. D. (1993). Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91, 2446-2452.
6. Epstein, M. A., and Barr, Y. M. (1964). Cultivation in vitro of human lymphoblasts from Burkitt's malignant lymphoma. Lancet 1, 252-253.
7. Epstein, M. A., and Barr, Y. M. (1965). Characteristics and mode of growth of a tissue culture strain (EB1) of human lymphoblasts from Burkitt's lymphoma. J. Natl. Cancer Inst. 34, 231-240.
8. Flemington, E., and Speck, S. (1990). Autoregulation of Epstein-Barr virus putative lytic switch gene BZLF1. J. Virol. 64, 1227-1232.
9. Flesch, I. E., Hess, J. H., Oswald, I. P., and Kufman, S. H. (1994). Grown inhibition of Mycobacterium bovis by IFN-gamma stimulated macrophages: Regulation by endogenous tumor necrosis factor-alpha and by IL-10. Int. Immunol. 6, 693-700.
10. Forstermann, U., Closs, E. I., Pollock, J. S., Nakane, M., Schwarz, P., Gath, I., and Kleinert, H. (1994). Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertention (Dallas) 23, 1121-1131.
11. 1 on the cell growth, and Epstein-Barr virus reactivation in EBV-infected epithelial cell lines. Virology 288, 109-118.
12. Gao, X., Tajima, M., and Sairenji, T. (1999). Nitric oxide down-regulates Epstein-Barr virus reactivation in epithelial cell lines. Virology 258, 375-381.
13. Gao, X., Ikuta, K., Tajima, M., and Sairenji, T. (2001). 12-O-tetradecanoyl-phorbol-13-acetate induces Epstein-Barr virus reactivation via NF-κB, and AP-1 as regulated by protein kinase C, and mitogen-activated protein kinase. Virology 286, 91-99.
14. Gerber, P. (1972). Activation of Epstein-Barr virus by 5-bromodeoxyuridine in "virus free" human cells. Proc. Natl. Acad. Sci. USA 69, 83-85.
15. Goldschmidts, W. L., Ginsburg, M., and Pearson, G. R. (1989). Neutralization of Epstein-Barr virus-induced ribonucleotide reductase with antibody to the major restricted early antigen polypeptide. Virology 170, 330-333.
16. 15N] nitrate in biological fluids. Anal. Biochem. 126, 131-138.
17. Greenspan, J. S., Greenspan, D., Lennette, E. T., Abrams, D. I., Conant, M. A., Petersen, M. V., and Freese, U. K. (1985). Replication of Epstein-Barr virus within the epithelial cells of oral "hairy" leukoplakia, an AIDS-associated lesion. N. Engl. J. Med. 313, 1564-1571.
18. Hampar, B., Derge, J. G., Martos, L. M., and Walker, J. L. (1972). Synthesis of Epstein-Barr virus after activation of the viral genome in a "virus negative" human lymphoblastoid cell (Raji) made resistant to 5-bromodeoxyuridine. Proc. Natl. Acad. Sci. USA 69, 78-82.
19. Hampar, B., Lenoir, G., Nonoyama, M., Derge, J. G., and Chang, S. (1976). Cell cycle dependence for activation of Epstein-Barr virus by inhibitors of protein synthesis or medium deficient in arginine. Virology 69, 660-668.
20. Harris, N., Buller, R. M. L., and Karupiah, G. (1995). Gamma interferon-induced, nitric oxide-mediated inhibition of vaccnia virus replication. J. Virol. 69, 910-915.
21. Henle, G., Henle, W., and Klein, G. (1971). Demonstration of two distinct components in the early antigen complex of Epstein-Barr virus infected cells. Int. J. Cancer 8, 272-282.
22. Henle, W., and Henle, G. (1968). Effect of arginine-deficient media on the herpes-type virus associated with cultured Burkitt tumor cells. J. Virol. 2, 182-191.
23. Henle, W., Henle, G., and Lennette, E. T. (1979). The Epstein-Barr virus. Sci. Am. 241, 48-59.
24. Heston, L., Rabson, M., Brown, N., and Miller, G. (1982). New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature 295, 160-163.
25. Hinuma, Y., Konn, M., Yamaguchi, T., Wudarski, D. J., Blakeslee, J. R., Jr., and Grace, J. T., Jr. (1967). Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line. J. Virol. 1, 1045-1051.
26. Hinuma, Y., Matsumoto, M., and Sairenji, T. (1980). Modulation of Epstein-Barr virus release from cells by components of normal human serum. J. Gen. Virol. 49, 197-201.
27. Kanamori, M., Murakami, M., Takahashi, T., Kamada, N., Tajima, M., Okinaga, K., Miyazawa, Y., Kurata, T., and Sairenji, T. (2001). Spontaneous reduction in Epstein-Barr virus (EBV) DNA copy number in EBV-infected epithelial cell lines. Microbes Infect. 3, 1085-91.
28. Karupiah, G., Xie, Q. W., Buller, R. M. L., Nathan, C., Duarte, C., and MacMicking, J. D. (1993). Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261, 1445-1448.
29. Kawanishi, M. (1995). Nitric oxide inhibits Epstein-Barr virus DNA replication and activation of latent EBV. Intervirology 38, 206-213.
30. Konn, M., Yamaguchi, J., Grace, J. T., Jr., and Hinuma, Y. (1969). Factors influencing the formation of immunofluorescent antigen in a Burkitt lymphoma cell line. Jpn. J. Microbiol. 13, 215-217.
31. Kurz, S., and Harrison, D. G. (1997). Insulin and the arginine paradox. J. Clin. Invest. 99, 369-370.
32. Luka, J., Kallin, B., and Klein, G. (1979). Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate. Virology 94, 228-231.
33. Mannick, J. B., Asano, K., Izumi, K., Kieff, E., and Stamler, J. S. (1994). Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 79, 1137-1146.
34. Matsumoto, M., Tada, Y., Yamaguchi, J., Sairenji, T., and Hinuma, Y. (1980). Further studies on inhibition of Epstein-Barr virus release by bovine serum: Partial purification and characterization of the inhibitor. J. Natl. Cancer Inst. 64, 353-358.
35. Mellinghoff, I., Daibata, M., Humphreys, R. E., Mulder, C., Takada, K., and Sairenji, T. (1991). Early events in Epstein-Barr virus genome expression after activation: Regulation by second messengers of B cell activation. Virology 185, 922-928.
36. Miller, G., Heston, L., and Countryman, J. (1985). P3HR-1 Epstein-Barr virus with heterogeneous DNA is an independent replicon maintained by cell-to-cell spread. J. Virol. 54, 45-52.
37. Moncada, S., Palmer, R. M. J., and Higgs, E. A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43, 109-142.
38. Nagoya, T., and Hinuma, Y. (1972). Production of infective Epstein-Barr virus in a Burkitt lymphoma cell line, P3HR-1. Gann 63, 87-93.
39. Nakamura, L. T., Wu-Hsieh, B. A., and Howard, D. H. (1994). Recombinant murine gamma interferon stimulates macrophages of the RAW cell line to inhibit intracellular growth of Histoplasma capsulatum. Infect. Immunol. 62, 680-684.
40. Nathan, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 3051-3064.
41. Nathan, C., and Hibbs, J. B., Jr. (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65-70.
42. Nathan, C., and Xie, Q. W. (1994). Nitric oxide synthases: Roles, tolls, and controls. Cell 78, 915-918.
43. Ohnishi, E., Iwata, T., Inoue, S., Kurata, T., and Sairenji, T. (1997). Interleukin-4 production in Epstein-Barr virus-transformed B cell lines from peripheral mononuclear cells of patients with atopic dermatitis. J. Interferon Cytokine Res. 17, 597-602.
44. Palmer, R. M. J., Ashton, D. S., and Moncada, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333, 664-666.
45. Park, K. G. M., Hayes, P. D., Garlick, P. J., Sewell, H., and Eremin, O. (1991). Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 337, 645-646.
46. Pathmanathan, R., Prasad, U., Sadler, R., Flynn, K., and Raab-Traub, N. (1995). Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N. Engl. J. Med. 333, 693-698.
47. Pelmont, J., and Morgan, H. R. (1959). Facteurs nutritifs influenceant la croissance du virus de l'herpes dans le souche de cellules de Earle. Ann. Inst. Pasteur 96, 448-454.
48. Penn, I. (1987). Cancers following cyclosporine therapy. Transplantation 43, 32-35.
49. Pope, M., Marsden, P. A., Cole, E., Sloan, S., Fung, L. S., Ning, Q., Ding, J. W., Leibowitz, J. L., Phillips, M. J., and Levy, G. A. (1998). Resistance to murine hepatitis virus strain 3 is dependent on production of nitric oxide. J. Virol. 72, 7084-7090.
50. Pulvertaft, R. J. V. (1965). A study of malignant tumors in Nigeria by short-term tissue culture. J. Clin. Pathol. 18, 261-271.
51. Rickinson, A. B. (1986). Chronic, symptomatic Epstein-Barr virus infections. Immunol. Today 7, 13-15.
52. Rickinson, A. B., Murray, R. J., Brooks, J., Griffin, H., Moss, D. J., and Masucci, M. G. (1992). T cell recognition of Epstein-Barr virus associated lymphomas [review]. Cancer Surv. 13, 53-80.
53. Rickinson, A. B., Lee, S. P., and Steven, N. M. (1996). Cytotoxic T lymphocyte responses to Epstein-Barr virus. Curr. Opin. Immunol. 8, 492-497.
54. Rodriguez, A., Jung, E. J., and Flemington, E. K. (2001). Cell cycle analysis of Epstein-Barr virus-infected cells following treatment with lytic cycle-inducing agents. J. Virol. 75, 4482-4489.
55. Sairenji, T., and Hinuma, Y. (1973). Assay of Epstein-Barr virus by immunofluorescence. Gann 64, 633-636.
56. Sairenji, T., and Hinuma, Y. (1970). Effect of neocarcinostatin on the cultured Burkitt lymphoma cells, with particular reference to the enhancement of production of Epstein-Barr virus. Gann 61, 451-460.
57. Sairenji, T., and Hinuma, Y. (1975). Inhibitory effect of adult bovine serum on release of infectious Epstein-Barr virus from a virus-carrier cell line. J. Natl. Cancer Inst. 55, 339-343.
58. Sairenji, T., and Hinuma, Y. (1980). Re-evaluation of a transforming strain of Epstein-Barr virus from the Burkitt lymphoma cell line, Jijoye. Int. J. Cancer 26, 337-342.
59. Sairenji, T., Bertoni, G., Medveczky, M. M., Medveczky, P. G., and Humphreys, R. E. (1991). Inhibition of Epstein-Barr virus production in P3HR-1 cells by Epstein-Barr virus-seropositive human serum. Intervirology 32, 37-51.
60. Sairenji, T., Bertoni, G., Medveczky, M. M., Medveczky, P. G., Nguyen, Q. V., and Humphreys, R. E. (1988). Inhibition of Epstein-Barr virus (EBV) release from P3HR-1 and B95-8 cell lines by monoclonal antibodies to EBV membrane antigen gp350/220. J. Virol. 62, 2614-2621.
61. Sairenji, T., Reisert, P. S., Spiro, R. C., Connolly, T., and Humphreys, R. E. (1985). Inhibition of Epstein-Barr virus release from the P3HR-1 Burkitt's lymphaoma cell line by a monoclonal antibody against a 200000 dalton EBV membrane antigen. J. Exp. Med. 161, 1097-1111.
62. Stenger, S., Thüring, H., Röllinghoff, M., and Bogdan, C. (1994). Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J. Exp. Med. 180, 783-793.
63. Stuehr, D. J., and Marletta, M. A. (1985). Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82, 7738-7742.
64. Sugawara, K., and Osato, T. (1973). Immunofluorescent antigen associated with Epstein-Barr virus induced by 5-iododeoxyuridine. Nat. New Biol. 246, 72-73.
65. Tajima, M., Komuro, M., and Okinaga, K. (1998). Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn. J. Cancer Res. 89, 262-268.
66. Takada, K. (1984). Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33, 27-32.
67. Takada, K., Shimizu, N., Sakuma, S., and Ono, Y. (1986). transactivation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J. Virol. 57, 1016-1022.
68. Tankersley, R. W., Jr. (1964). Amino acid requirements of herpes simplex virus in human cells. J. Bacteriol. 87, 609-613.
69. Tsurumi, T., Kobayashi, A., Tamai, K., Ymada, H., Daikoku, A. T., Yamashita, Y., and Nishiyama, Y. (1996). Epstein-Barr virus single stranded DNA-binding protein: Purification, characterization, and action on DNA synthesis by the viral DNA polymerase. Virology 222, 352-364.
70. Wang, J. H., Ko, G. Y. P., and Kelly, P. T. (1997). Cellular and molecular bases of memory: Synaptic and neuronal plasticity. J. Clin. Neurophysiol. 14, 264-293.
71. Weinberg, A., and Becker, Y. (1969). Studies on EB virus of Burkitt's lymphoblasts. Virology 39, 312-321.
72. Wood, K. S., Buga, G. M., Byrns, R. E., and Ignarro, L. J. (1990). Vascular smooth muscle-derived relaxing factor (MDRF) and its close similarity to nitric oxide. Biochem. Biophys. Res. Commun. 170, 80-88.
73. zur Hausen, H., O'Neill, F. J., and Freese, U. K. (1978). Persisting oncogenic herpesvirus induced by the tumour promoter TPA. Nature 272, 373-375.